Download PDF
Am J Perinatol 2007; 24(7): 429-434
DOI: 10.1055/s-2007-984409
Copyright © 2007 by Thieme Medical Publishers, Inc., 333 Seventh Avenue, New York, NY 10001, USA.

CMV-Induced Neonatal Thrombocytopenia: A Case Report and Review of the Literature

Muhammad Aslam1 , 2 , Jennifer L. Anderson1 , 2 , Deborah Guglietti2 , Dorcas Cardwell2
  • 1Harvard Neonatal-Perinatal Fellowship Program, Children's Hospital Boston, Boston, Massachusetts
  • 2Department of Newborn Medicine, Children's Hospital Boston, Boston, Massachusetts
Further Information

Publication History

Publication Date:
27 June 2007 (online)

    Permissions and Reprints

ABSTRACT

Cytomegalovirus (CMV) is a member of the Herpesviridae family of DNA viruses. It is unique in its ability to cause latent infection with secondary reactivation. Neonatal infection results from congenital and/or perinatal transmission. We present the case of a full-term infant with petechiae and splenomegaly at birth with no significant antenatal history. She was noted to have thrombocytopenia, but maternal platelet count was normal. Routine workup was normal, which prompted evaluation for toxoplasmosis, other infections, rubella, cytomegalovirus, and herpes simplex (TORCH infection); she was noted to have a positive urine CMV. She received multiple platelet transfusions and after consultation with an infectious disease specialist, she was started on intravenous (IV) ganciclovir. She continued to have persistent thrombocytopenia and received three doses of CMV immunoglobulin with gradual resolution. IV ganciclovir was changed to oral valganciclovir for a total treatment duration of 6 weeks. She failed her hearing screen, but eye examination was normal. She was discharged home after clinical stabilization with a close follow-up.

KEYWORDS

Cytomegalovirus - thrombocytopenia - TORCH - hearing loss - intracranial calcifications - ganciclovir - CMV immunoglobulin

REFERENCES

  • 1 Demmler G J. Cytomegalovirus. In: Feigin RD, Cherry JD, Demmler GJ, Kaplan SL Textbook of Pediatric Infectious Diseases. 5th ed. Philadelphia; Saunders 2004: 1912
    Google Scholar
  • 2 Mocarski E S. Cytomegaloviruses and their replication. In: Fields B, Knipe D, Howley P Virology. Vol. 2. 3rd ed. Philadelphia; Lippincott-Raven 1996: 2447
    Google Scholar
  • 3 Walker A, Petheram S J, Ballard L et al.. Characterization of human cytomegalovirus strains by analysis of short tandem repeat polymorphisms.  J Clin Microbiol. 2001;  39 2219-2226
    CrossrefPubMedGoogle Scholar
  • 4 Demmler G J. Infectious Diseases Society of America and Centers for Disease Control. Summary of a workshop on surveillance for congenital cytomegalovirus disease.  Rev Infect Dis. 1991;  13 315-329
    CrossrefPubMedGoogle Scholar
  • 5 Hamprecht K, Maschmann J, Vochem M et al.. Epidemiology of transmission of cytomegalovirus from mother to preterm infant by breastfeeding.  Lancet. 2001;  357 513-518
    CrossrefPubMedGoogle Scholar
  • 6 Maschmann J, Hamprecht K, Dietz K et al.. Cytomegalovirus infection of extremely low-birth weight infants via breast milk.  Clin Infect Dis. 2001;  33 1998-2003
    CrossrefPubMedGoogle Scholar
  • 7 Neuberger P, Hamprecht K, Vochem M et al.. Case-control study of symptoms and neonatal outcome of human milk-transmitted cytomegalovirus infection in premature infants.  J Pediatr. 2006;  148 326-331
    CrossrefPubMedGoogle Scholar
  • 8 Malm G, Engman M L. Congenital cytomegalovirus infections.  Semin Fetal Neonatal Med. 2007;  12 154-159
    CrossrefPubMedGoogle Scholar
  • 9 Fowler K B, Stagno S, Pass R F. Maternal age and congenital cytomegalovirus infection: screening of two diverse newborn populations, 1980-1990.  J Infect Dis. 1993;  168 552-556
    CrossrefPubMedGoogle Scholar
  • 10 Kylat R I, Kelly E N, Ford-Jones E L. Clinical findings and adverse outcome in neonates with symptomatic congenital cytomegalovirus (SCCMV) infection.  Eur J Pediatr. 2006;  165 773-778
    CrossrefPubMedGoogle Scholar
  • 11 Noyola D E, Demmler G J, Nelson C T et al.. Early predictors of neurodevelopmental outcome in symptomatic congenital cytomegalovirus infection.  J Pediatr. 2001;  138 325-331
    CrossrefPubMedGoogle Scholar
  • 12 Boppana S B, Fowler K B, Vaid Y et al.. Neuroradiographic findings in the newborn period and long-term outcome in children with symptomatic congenital cytomegalovirus infection.  Pediatrics. 1997;  99 409-414
    CrossrefPubMedGoogle Scholar
  • 13 Coats D K, Demmler G J, Paysse E A et al.. Ophthalmologic findings in children with congenital cytomegalovirus infection.  J AAPOS. 2000;  4 110-116
    CrossrefPubMedGoogle Scholar
  • 14 Istas A S, Demmler G J, Dobbins J G et al.. Surveillance for congenital cytomegalovirus disease: a report from the National Congenital Cytomegalovirus Disease Registry.  Clin Infect Dis. 1995;  20 665-670
    PubMedGoogle Scholar
  • 15 Hicks T, Fowler K, Richardson M et al.. Congenital cytomegalovirus infection and neonatal auditory screening.  J Pediatr. 1993;  123 779-782
    PubMedGoogle Scholar
  • 16 Williamson W D, Demmler G J, Percy A K, Catlin F I. Progressive hearing loss in infants with asymptomatic congenital cytomegalovirus infection.  Pediatrics. 1992;  90 862-866
    PubMedGoogle Scholar
  • 17 Fowler K B, McCollister F P, Dahle A J et al.. Progressive and fluctuating sensorineural hearing loss in children with asymptomatic congenital cytomegalovirus infection.  J Pediatr. 1997;  130 624-630
    PubMedGoogle Scholar
  • 18 Boppana S B, Fowler K B, Pass R F et al.. Congenital cytomegalovirus infection: association between virus burden in infancy and hearing loss.  J Pediatr. 2005;  146 817-823
    PubMedGoogle Scholar
  • 19 Ross S A, Fowler K B, Ashrith G et al.. Hearing loss in children with congenital cytomegalovirus infection born to mothers with preexisting immunity.  J Pediatr. 2006;  148 332-336
    PubMedGoogle Scholar
  • 20 Jones R N, Neale M L, Beattie B et al.. Development and application of a PCR-based method including an internal control for diagnosis of congenital cytomegalovirus infection.  J Clin Microbiol. 2000;  38 1-6
    PubMedGoogle Scholar
  • 21 Grazia Revello M, Zavattoni M, Sarasini A et al.. Prenatal diagnostic and prognostic value of human cytomegalovirus load and IgM antibody response in blood of congenitally infected fetuses.  J Infect Dis. 1999;  180 1320-1323
    CrossrefPubMedGoogle Scholar
  • 22 Nelson C T, Istas A S, Wilkerson M K, Demmler G J. PCR detection of cytomegalovirus DNA in serum as a diagnostic test for congenital cytomegalovirus infection.  J Clin Microbiol. 1995;  33 3317-3318
    PubMedGoogle Scholar
  • 23 Demmler G J, Buffone G J, Schimbor C M, May R A. Detection of cytomegalovirus in urine from newborns by using polymerase chain reaction DNA amplification.  J Infect Dis. 1988;  158 1177-1184
    CrossrefPubMedGoogle Scholar
  • 24 Whitley R J, Cloud G, Gruber W et al.. Ganciclovir treatment of symptomatic congenital cytomegalovirus infection: results of a phase II study.  J Infect Dis. 1997;  175 1080-1086
    PubMedGoogle Scholar
  • 25 Kimberlin D W, Lin C Y, Sanchez P J et al.. Effect of ganciclovir therapy on hearing in symptomatic congenital cytomegalovirus disease involving the central nervous system: a randomized, controlled trial.  J Pediatr. 2003;  143 16-25
    CrossrefPubMedGoogle Scholar
  • 26 Crumpacker C S. Ganciclovir.  N Engl J Med. 1996;  335 721-729
    CrossrefPubMedGoogle Scholar
  • 27 Vallejo J G, Englund J A, Garcia-Prats J A, Demmler G J. Ganciclovir treatment of steroid-associated cytomegalovirus disease in a congenitally infected neonate.  Pediatr Infect Dis J. 1994;  13 239-241
    PubMedGoogle Scholar
  • 28 Nigro G, Scholz H, Bartmann U. Ganciclovir therapy for symptomatic congenital cytomegalovirus infection in infants: a two-regimen experience.  J Pediatr. 1994;  124 318-322
    PubMedGoogle Scholar
  • 29 Xu H R, Li X N, Chen W L, Liu G Y. Chu NN, Yu C. A sensitive assay for simultaneous determination of plasma concentrations of valganciclovir and its active metabolite ganciclovir by LC/MS/MS.  J Chromatogr B Analyt Technol Biomed Life Sci. 2007;  848 329-334
    PubMedGoogle Scholar
  • 30 Adler S P, Nigro G, Pereira L. Recent advances in the prevention and treatment of congenital cytomegalovirus infections.  Semin Perinatol. 2007;  31 10-18
    CrossrefPubMedGoogle Scholar
  • 31 Plotkin S A. Vaccination against cytomegalovirus, the changeling demon.  Pediatr Infect Dis J. 1999;  18 313-325
    CrossrefPubMedGoogle Scholar
  • 32 Pass R F, Duliege A M, Boppana S et al.. A subunit cytomegalovirus vaccine based on recombinant envelope glycoprotein B and a new adjuvant.  J Infect Dis. 1999;  180 970-975
    CrossrefPubMedGoogle Scholar
  • 33 American College of Obstetricians and Gynecologists (ACOG) .Perinatal viral and parasitic infections. Washington, DC; American College of Obstetricians and Gynecologists 2000 13. ACOG practice bulletin, no. 20
    Google Scholar

Muhammad AslamM.D. 

Harvard Neonatal-Perinatal Fellowship Program, Children's Hospital Boston

300 Longwood Avenue, Boston, MA 02115

      >